FDA highlights next steps for bisphenol A assessment

摘要

FDA plans to open a public docket on bisphenol A, seeking comment on the agency's review of low dose toxicity studies and recently published research, independent evaluations FDA's chief scientist asked five government experts to conduct, and other materials.